By Fineline Cube China Innovation Instrument (Cii Tech), a life sciences instrument maker based in Ningbo, has reportedly raised “tens of millions” of renminbi in a Pre-Series A financing round. The funding was solely led by a fund from Oak Acorn Capital. The proceeds will be allocated towards the research and development of high-end mass spectrometer instruments, further enhancing Cii Tech’s capabilities in advanced analytical technologies.
Company Overview and Technology
Founded in 2015, Cii Tech has established itself as a leader in the development of mass spectrometers and supporting equipment. The company offers a comprehensive suite of products, including pre-treatment equipment, reagents, mobile laboratories, and information software platforms. These solutions are tailored for various markets, including public safety, food and drug safety, and medical inspection. Cii Tech’s direct ionization mass spectrometry technology is particularly notable, having been described as “first-in-class” for its innovative approach and high performance.
Future Outlook
The Pre-Series A financing round marks a significant milestone for Cii Tech, positioning the company to accelerate its R&D efforts and bring next-generation mass spectrometer instruments to market. With strong financial backing and a proven track record in advanced analytical technologies, Cii Tech is poised to drive innovation and address significant unmet needs in multiple sectors. The company’s commitment to developing high-end instruments underscores its dedication to advancing life sciences and improving public health and safety.-Fineline Info & Tech